Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?

Detalles Bibliográficos
Autores principales: Kunos, George, Jourdan, Tony, Tam, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718143/
https://www.ncbi.nlm.nih.gov/pubmed/34981780
http://dx.doi.org/10.1172/JCI155330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718143/
https://www.ncbi.nlm.nih.gov/pubmed/34981780
http://dx.doi.org/10.1172/JCI155330

Ejemplares similares